Epicrispr Biotechnologies to Begin Clinical Trials for its Lead Epigenetic Therapy for FSHD Patients
The therapy, EPI-321, is intended to treat cases of facioscapulohumeral muscular dystrophy, a genetic neuromuscular disorder.
The goal is to close the gap on hybrids in the U.S. over the next 24 months. The fourth-generation Rogue compact SUV goes into production in 2026 and will finally bring Nissan's e-Power hybrid setup ...
Juan Soto, Blake Snell and Clay Holmes debut for new teams. Paul Skenes makes his first opening-day start at age 22 and Sandy Alcántara returns from Tommy John surgery. A ...
Juan Soto, Blake Snell and Clay Holmes debut for new teams. Paul Skenes makes his first opening-day start at age 22 and Sandy ...
Samsung Electronics America has announced the global availability of its 2025 Neo QLED 8K TV series, which includes the ...
Catcher Cal Raleigh and the Seattle Mariners have finalized a $105 million, six-year contract. Raleigh’s deal supersedes a $5 ...
Samsung's QLED TVs will be available in sizes up to 115 inches. They promise more AI enhancements and some big prices.
The Los Angeles Dodgers say they have accepted President Donald Trump's invitation to the White House to celebrate their ...
A Peninsula biotech company raised $68 million from investors — including a venture philanthropy fund started by Lululemon ...
The startup is using CRISPR tools to stop errant expression of a gene linked to facioscapulohumeral muscular dystrophy, a disorder on the radars of several drugmakers.
The Dodgers have spent a lot of money hoping to win their second straight World Series and bettors are putting their cash on ...
Toronto Blue Jays catcher Alejandro Kirk has finalized a $58 million, five-year contract covering 2026-30. Kirk agreed in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results